Calibr, the drug discovery division of Scripps Research, is home to ReFRAME, the world’s leading collection of drugs known to be safe in humans. During the COVID-19 pandemic, the institute combed this collection to identify medicines that could be rapidly repurposed against the novel coronavirus and, to further speed the process, shared the collection with other institutes. Cures Within Reach, a philanthropic leader supporting medical repurposing research, recognized the value of this approach with its 2021 Janet Davison Rowley Patient Impact Research Award. In a statement, the organization wrote: “We celebrate Calibr’s commitment to the database’s ease of accessibility and the collaboration made possible through this technology, especially during the COVID-19 pandemic.